Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2024

1.
2.

Comparative Effectiveness of Treatments To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis [Internet].

MacLean C, Alexander A, Carter J, Chen S, Desai SB, Grossman J, Maglione M, McMahon M, McNamara M, Mojica W, Newberry S, Ranganath V, Suttorp M, Timmer M, Tringale C, Valentine D, Zhou A.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Dec.

3.

Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis - a clinical update on efficacy and safety.

Deal CL, Draper MW.

Womens Health (Lond Engl). 2006 Mar;2(2):199-210. doi: 10.2217/17455057.2.2.199.

PMID:
19803890
[PubMed]
4.

Pharmacological interventions for preventing complications in idiopathic hypercalciuria.

Escribano J, Balaguer A, Pagone F, Feliu A, Roqué I Figuls M.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004754. doi: 10.1002/14651858.CD004754.pub2. Review.

PMID:
19160242
[PubMed - indexed for MEDLINE]
5.

The use of bisphosphonates in the treatment of osteoporosis.

Russo MS, Panebianco P, Di Stefano F, Scarpinato RA, Destro G, Salamone SA, Tropea S, Rizzo A, Mauceri D.

Arch Gerontol Geriatr. 1996;22 Suppl 1:551-5.

PMID:
18653093
[PubMed]
6.

Interventions for preventing bone disease in kidney transplant recipients.

Palmer SC, McGregor DO, Strippoli GF.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. Review.

PMID:
17636784
[PubMed - indexed for MEDLINE]
7.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
[PubMed - indexed for MEDLINE]
8.

Weekly oral alendronic Acid in male osteoporosis.

Miller PD, Schnitzer T, Emkey R, Orwoll E, Rosen C, Ettinger M, Vandormael K, Daifotis A.

Clin Drug Investig. 2004;24(6):333-41.

PMID:
17516720
[PubMed]
9.

Alendronate and atrial fibrillation.

Cummings SR, Schwartz AV, Black DM.

N Engl J Med. 2007 May 3;356(18):1895-6. No abstract available.

PMID:
17476024
[PubMed - indexed for MEDLINE]
Free Article
10.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR; HORIZON Pivotal Fracture Trial.

N Engl J Med. 2007 May 3;356(18):1809-22.

PMID:
17476007
[PubMed - indexed for MEDLINE]
Free Article
11.

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.

Recker RR, Kendler D, Recknor CP, Rooney TW, Lewiecki EM, Utian WH, Cauley JA, Lorraine J, Qu Y, Kulkarni PM, Gaich CL, Wong M, Plouffe L Jr, Stock JL.

Bone. 2007 Apr;40(4):843-51. Epub 2006 Dec 19.

PMID:
17182297
[PubMed - indexed for MEDLINE]
12.

Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone.

Mikati MA, Dib L, Yamout B, Sawaya R, Rahi AC, Fuleihan Gel-H.

Neurology. 2006 Dec 12;67(11):2005-14.

PMID:
17159108
[PubMed - indexed for MEDLINE]
13.

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.

Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R.

Osteoporos Int. 2007 Jan;18(1):25-34. Epub 2006 Nov 15.

PMID:
17106785
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005326. Review.

PMID:
17054253
[PubMed - indexed for MEDLINE]
15.

Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial.

Greenspan SL, Bhattacharya RK, Sereika SM, Brufsky A, Vogel VG.

J Clin Endocrinol Metab. 2007 Jan;92(1):131-6. Epub 2006 Oct 17.

PMID:
17047022
[PubMed - indexed for MEDLINE]
16.

Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease.

Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Suzuki S, Miura S.

Nephrol Dial Transplant. 2007 Jun;22(6):1593-600. Epub 2006 Oct 13.

PMID:
17041001
[PubMed - indexed for MEDLINE]
Free Article
17.

An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment.

Gallagher JC, Rapuri PB, Smith LM.

J Clin Endocrinol Metab. 2007 Jan;92(1):51-8. Epub 2006 Oct 10.

PMID:
17032712
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials.

Liberman UA, Hochberg MC, Geusens P, Shah A, Lin J, Chattopadhyay A, Ross PD.

Int J Clin Pract. 2006 Nov;60(11):1394-400. Epub 2006 Oct 4. Review.

PMID:
17026515
[PubMed - indexed for MEDLINE]
19.

Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.

Rhee Y, Kang M, Min Y, Byun D, Chung Y, Ahn C, Baek K, Mok J, Kim D, Kim D, Kim H, Kim Y, Myoung S, Kim D, Lim SK.

Osteoporos Int. 2006 Dec;17(12):1801-7. Epub 2006 Sep 26.

PMID:
17019520
[PubMed - indexed for MEDLINE]
20.

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH.

Osteoporos Int. 2007 Jan;18(1):59-68. Epub 2006 Sep 30.

PMID:
17013567
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk